The December 14, 2021, session of Duke Medicine LEADS featured Katherine Garman, MD presenting "Opportunities to Address Disparities in H. Pylori, Gastric Intestinal Metaplasia, and Gastric Cancer."
Gastric cancer has one of the highest racial disparities amongst all cancers, and is the 6th leading cause of cancer death in black patients.
H. pylori infection portends a significant risk for the development of gastric cancer. It is imperative not only to ensure that patients are appropriately screened per the 2017 AGA criteria, but that they also have confirmatory eradication testing.
Our understanding of gastric intestinal metaplasia (IM) is increasing, and accurately quantifying disease spread and histologic type has prognostic significance. It is appropriate to treat H. pylori infection in these patients.
Future directions include learning more about H. pylori antibiotic resistant, developing better risk stratification models, and ensuring consistency in our guideline practices.
Duke Medicine Learning, Education, and Discussion Series (LEADS) takes place each Tuesday at 12 p.m. Learn more and see schedule of upcoming sessions.